Stroke
-
In the Lab The Kaiser lab specializes in investigating sex differences in the pathophysiology of stroke, traumatic brain injury, and vascular cognitive impairment. Within the lab, the Kaiser team employs clinically relevant assessments, including magnetic resonance imaging, to evaluate tissue-level changes. Additionally, they utilize gait and neurobehavioral tests to assess functional-level outcomes in response to…
-
In the Lab Kinder’s research focus is in the area of regenerative bioscience with an emphasis in stem cell therapies for traumatic brain injury (TBI) and stroke. TBI and stroke are leading causes of death and disability in the United States. However, there are currently no Food and Drug Administration (FDA)-approved therapies that promote healing…
-
In the Lab The Anantharam lab research focuses on neurodegenerative diseases and neurotoxicology, specifically, mitochondrial dysfunction, oxidative stress, protein aggregation, neuroinflammation and apoptosis in neurotoxicity models of Parkinson’s and prion diseases. Dr. Anantharam’s primary focus is translational research, and has extensive experience with the science of developing neuroprotective drugs and testing their efficacy in both…
-
In the Lab Reproductive challenges in both human and livestock populations are of significant concern and are often a direct result of abnormal germ cell (oocyte and sperm) development. Aberrant germ cell development significantly affects human fertility, is the leading cause of early pregnancy loss and results in birth defects such as Down’s syndrome and…
-
Stice Bio Dr. Steve Stice is a University of Georgia, DW Brooks Distinguished Professor and Director of the Regenerative Bioscience Center, who holds a Georgia Research Alliance Eminent Scholar endowed chair, and is CSO of Aruna Biomedical Inc. He has over 35 years of research and development experience in biotechnology and is a co-founder of…
-
In the Lab Functional heterogeneity is a significant barrier to the clinical translation of many cellular therapies, including mesenchymal stromal cells (MSCs). Though MSCs have shown promise in treatment of immune diseases, the mechanisms of action and critical quality attributes (CQAs, predictors of function) in different therapeutic settings are largely unknown. The overall goal of the…